Acupuncture may help treat amblyopia

Article

A study from the Archives of Ophthalmology has shown that acupuncture may be as effective as using an eye patch to treat anisometropic amblyopia.

A study from the Archives of Ophthalmology has shown that acupuncture may be as effective as using an eye patch to treat anisometropic amblyopia.

The randomized, controlled study of 88 children aged between 7 and 12 years revealed that using acupuncture was statistically superior to patching. Half of the patients received five sessions of acupuncture weekly and the other half received two hours of patching a day. They also received regular optical correction and one hour of near-vision activity daily.

The results demonstrated that the mean best spectacle-corrected visual acuity (BSCVA) improved by 1.83 and 2.27 in the patching and acupuncture groups respectively. The mean difference in BSCVA between the groups was 0.049 logMAR. With patching, BSCVA had improved by two lines or more in 28 eyes (66.7%) compared with 31 eyes (75.6%) in the acupuncture groups. Amblyopia was treated in seven eyes in the patching group and 17 in the acupuncture group.

To conclude, acupuncture is effective as a potential alternative treatment to occlusion therapy, and is being studied further to evaluate its value as a treatment for amblyopia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.